Brian Taylor Slingsby
Director at Mineralys Therapeutics. Based in Seattle, Washington.
- Rank
- 1383rd of 14,452
- Companies held
- 1
- Largest holding
- MLYS, 100.0% of total
- Latest SEC filing
- Sep 22, 2026
- Listed but not counted
- $111M
What the $112M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Mineralys Therapeutics MLYS Common Stock | Indirectly (see filing footnote) | 7,910,038 | $14.16 | $112M | 100.0% | Form 4, Feb 19, 2026 |
Share counts are the amounts Brian Taylor Slingsby reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Brian Taylor Slingsby's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Mineralys Therapeutics MLYS Common Stock | Through Catalys Pacific Fund, LP Held by a company or fund the insider manages | 7,805,718 | $14.16 | $111M | — | Form 4, Sep 22, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1380 | Charles V Bergh Executive Vice Chair, Levi Strauss &. Oakland, CA | $112M |
| 1381 | Shizhong Ding Director, Amer Sports | $112M |
| 1382 | George W. LeMaitre Chairman and CEO, LeMaitre Vascular. Burlington, MA | $112M |
| 1383 | Brian Taylor Slingsby Director, Mineralys Therapeutics. Seattle, WA | $112M |
| 1384 | Seth A. Ravin President, CEO & Chairman, Rimini Street. Las Vegas, NV | $112M |
| 1385 | Mark Chin Director, Enliven Therapeutics. Boston, MA | $112M |
| 1386 | Martin L. Flanagan President & CEO, Invesco. Atlanta, GA | $112M |
Other Mineralys Therapeutics insiders
All MLYS insiders- Jon Congleton$7.5MChief Executive Officer. #10851 overall
Questions
How much stock does Brian Taylor Slingsby own?
Brian Taylor Slingsby holds $112,006,138 in listed stock based on SEC filings and current prices, mostly Mineralys Therapeutics (MLYS). That ranks 1383rd on the Stock Rich List.
Is this Brian Taylor Slingsby's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Brian Taylor Slingsby last buy or sell stock?
The most recent open-market trade on file is a sale of 104,320 MLYS shares on Sep 22, 2026 at $28.81.